Key facts
- It has raised $6.1M; the latest was Accelerator/Incubator ($70K) in Sep 2024.
- Notable investors include Hub71, MIT Solve, Acelerar España, Johnson & Johnson Services, Sonen Capital — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Mamotest
- ·The full record, as it builds
Funding rounds
No funding rounds for Mamotest are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mamotest
Operator of a telemammography network intended to democratize access to breast cancer screening and early detection.The company offers a network of standardized, certified telemammography centers equipped with digital mammography technology and remote expert interpretation, enabling customers, particularly in underserved regions, to access high-quality, affordable breast cancer screening and receive timely diagnoses, ultimately improving survival rates and reducing disparities in healthcare access.
- Sector
- Healthcare
- HQ
- Mexico City, Mexico
- Founded
- 2013
- Employees
- 29
- Website
- mamotest.com/
- Ownership
- Privately Held (backing)
Mamotest doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mamotest shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mamotest in its N-PORT filings yet. We sweep new filings monthly.